IMUGENE CHART. TA only, page-30002

Nobody should be encouraging or happy with 'going it alone'. This whole company was founded on the basis to sell / licence new tech to BP. Going it alone, means a FAILURE of said game plan - they either couldn't land a deal or the deal they did receive was not sufficient enough for the board and SH, it would add many more years of research & development, less value for SH, more Capital Raises. Not to mention the competition of BP around the world in these spaces.

IMO this going it alone path needs to be vehemently shunned by all investors! The only positive I see of going it alone is for management's pockets getting handsomely paid for another 10years. No thank you, not what we signed up for.